Bram Herman is the Director of Emerging Technologies in the Genomics R&D division at Agilent Technologies. With a Ph. D. from the University of Warwick, he leads a team focused on technical M&A diligence and driving innovation by evaluating emerging technologies and applications in genomics.
He is deeply engaged in the scientific community, evidenced by his publications on sensitive mutation detection and his active promotion of innovative solutions and partnerships in his field. He also shows an interest in continuous learning, sharing courses he has found valuable.
Unique fact: Bram holds a patent for a method that uses CAS9 technology for fragmenting genomic DNA.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.